GROUP ONE TRADING, L.P. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 2 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$18,123
+483.7%
2,100
+600.0%
0.00%
Q2 2023$3,105
-97.2%
300
-97.1%
0.00%
Q1 2023$110,670
-88.4%
10,200
-88.0%
0.00%
-100.0%
Q4 2022$951,456
+359.6%
84,800
+315.7%
0.00%
Q3 2022$207,000
+146.4%
20,400
+119.4%
0.00%
Q2 2022$84,000
+500.0%
9,300
+520.0%
0.00%
Q1 2022$14,000
-94.4%
1,500
-93.4%
0.00%
Q4 2021$250,000
-67.9%
22,600
-78.5%
0.00%
-100.0%
Q3 2021$778,000
+245.8%
105,200
+9463.6%
0.00%
Q1 2021$225,000
+226.1%
1,100
-71.8%
0.00%
Q4 2020$69,000
+1625.0%
3,900
+1850.0%
0.00%
Q2 2020$4,000
-97.7%
200
-97.3%
0.00%
-100.0%
Q1 2020$171,000
+338.5%
7,400
+393.3%
0.00%
Q4 2019$39,000
-20.4%
1,500
-40.0%
0.00%
Q3 2019$49,000
-47.3%
2,500
-56.1%
0.00%
-100.0%
Q2 2019$93,000
-7.9%
5,700
+83.9%
0.00%0.0%
Q3 2018$101,000
-44.2%
3,100
-41.5%
0.00%
-50.0%
Q3 2017$181,000
-77.3%
5,300
-78.8%
0.00%
-75.0%
Q4 2016$797,000
+193.0%
25,000
+233.3%
0.01%
+166.7%
Q3 2016$272,000
+41.7%
7,500
-26.5%
0.00%0.0%
Q1 2016$192,000
+1100.0%
10,200
+920.0%
0.00%
Q4 2015$16,000
+300.0%
1,000
+150.0%
0.00%
Q3 2015$4,000
+33.3%
400
+100.0%
0.00%
Q2 2015$3,000
-75.0%
200
-71.4%
0.00%
Q1 2015$12,0007000.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 3,900$69,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders